These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21372722)
21. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related]
22. Quetiapine: efficacy and tolerability in schizophrenia. Kasper S; Tauscher J; Heiden A Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888 [TBL] [Abstract][Full Text] [Related]
23. Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies. Citrome L; Jaffe A; Levine J; Lindenmayer JP J Clin Psychiatry; 2005 Dec; 66(12):1512-6. PubMed ID: 16401150 [TBL] [Abstract][Full Text] [Related]
24. Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Katzman MA; Brawman-Mintzer O; Reyes EB; Olausson B; Liu S; Eriksson H Int Clin Psychopharmacol; 2011 Jan; 26(1):11-24. PubMed ID: 20881846 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study. Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481 [TBL] [Abstract][Full Text] [Related]
26. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582 [TBL] [Abstract][Full Text] [Related]
27. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Citrome L Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634 [TBL] [Abstract][Full Text] [Related]
29. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907 [TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719 [TBL] [Abstract][Full Text] [Related]
31. Quetiapine in schizophrenia: onset of action within the first week of treatment. Small JG; Kolar MC; Kellams JJ Curr Med Res Opin; 2004 Jul; 20(7):1017-23. PubMed ID: 15265246 [TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies. Meulien D; Huizar K; Brecher M Hum Psychopharmacol; 2010 Mar; 25(2):103-15. PubMed ID: 20196185 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Buckley PF Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of atypical antipsychotics in elderly patients with dementia. Tariot PN; Profenno LA; Ismail MS J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966 [TBL] [Abstract][Full Text] [Related]
35. Quetiapine: dose-response relationship in schizophrenia. Sparshatt A; Jones S; Taylor D CNS Drugs; 2008; 22(1):49-68; discussion 69-72. PubMed ID: 18072814 [TBL] [Abstract][Full Text] [Related]
36. [Quetiapine in the treatment of acute mania]. Bräunig P Psychiatr Prax; 2006 Mar; 33 Suppl 1():S27-31. PubMed ID: 16511728 [TBL] [Abstract][Full Text] [Related]
37. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027 [TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia. Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369 [TBL] [Abstract][Full Text] [Related]
40. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials. Suppes T; Vieta E; Gustafsson U; Ekholm B Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]